Consequences of superovulation and ART procedures

Seminars in Reproductive Medicine

Volumn 30, Issue 2, 2012, Pages 77-83

  Weinerman, Rachel ^a   Grifo, Jamie ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

complications; ectopic pregnancy; IVF; OHSS; Superovulation

Indexed keywords

GONADORELIN ANTAGONIST;

ARTICLE; BLEEDING; CONTROLLED CLINICAL TRIAL (TOPIC); ECTOPIC PREGNANCY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; INFECTION; INFERTILITY THERAPY; INTESTINE INJURY; MULTIPLE PREGNANCY; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PATIENT SAFETY; RISK ASSESSMENT; SUPEROVULATION; THROMBOEMBOLISM; UTERINE TUBE TORSION;

ADNEXAL DISEASES; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, ECTOPIC; PREGNANCY, MULTIPLE; REPRODUCTIVE TECHNIQUES, ASSISTED; SEVERITY OF ILLNESS INDEX; SUPEROVULATION; THROMBOEMBOLISM; TORSION ABNORMALITY;

EID: 84860290379     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0032-1307415     Document Type: Article

References (56)

1. Nygren KG, Sullivan E, Zegers-Hochschild F., et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003. Fertil Steril: 2011; 95 7 2209 2222, 2222, e1-e17
2. Vloeberghs V, Peeraer K, Pexsters A, D'Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol: 2009; 23 5 691 709
3. Zivi E, Simon A, Laufer N. Ovarian hyperstimulation syndrome: definition, incidence, and classification. Semin Reprod Med: 2010; 28 6 441 447
4. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv: 1989; 44 6 430 440 (Pubitemid 19138981)
5. Agents stimulating gonadal. Report of a WHO scientific group function in the human. World Health Organ Tech Rep Ser: 1973; 514 1 30
6. Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet: 2010; 27 2-3 121 128
7. Papanikolaou EG, Tournaye H, Verpoest W., et al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod: 2005; 20 3 636 641 (Pubitemid 40425488)
8. Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril: 2008; 90 5, Suppl S188 S193
9. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril: 1992; 58 2 249 261
10. Neulen J, Yan Z, Raczek S., et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab: 1995; 80 6 1967 1971
11. Griesinger G. Ovarian hyperstimulation syndrome prevention strategies: use of gonadotropin-releasing hormone antagonists. Semin Reprod Med: 2010; 28 6 493 499
12. D'Angelo A, Brown J, Amso NN. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev: 2011; 6 6 CD002811
13. D'Angelo A, Amso N. Embryo freezing for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev: 2007; 3 3 CD002806
14. Youssef MA, Al-Inany HG, Evers JL, Aboulghar M. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev: 2011; 2 2 CD001302
15. Rosenwaks Z, Benadiva C. An eye to the future. Semin Reprod Med: 2010; 28 6 540
16. Bodri D, Guilln JJ, Galindo A, Matar D, Pujol A, Coll O. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril: 2009; 91 2 365 371
17. Galindo A, Bodri D, Guilln JJ, Colodrn M, Vernaeve V, Coll O. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial. Gynecol Endocrinol: 2009; 25 1 60 66
18. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril: 2008; 89 1 84 91
19. Smitz JE, Thompson JG, Gilchrist RB. The promise of in vitro maturation in assisted reproduction and fertility preservation. Semin Reprod Med: 2011; 29 1 24 37
20. Källn B. Maternal morbidity and mortality in in-vitro fertilization. Best Pract Res Clin Obstet Gynaecol: 2008; 22 3 549 558
21. Aurousseau MH, Samama MM, Belhassen A, Herve F, Hugues JN. Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum Reprod: 1995; 10 1 94 97
22. Braat DDM, Schutte JM, Bernardus RE, Mooij TM, van Leeuwen FE. Maternal death related to IVF in the Netherlands 1984-2008. Hum Reprod: 2010; 25 7 1782 1786
23. Chan WS. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol: 2009; 21 3 207 218
24. Gelbaya TA. Short and long-term risks to women who conceive through in vitro fertilization. Hum Fertil (Camb): 2010; 13 1 19 27
25. Hurwitz A, Milwidsky A, Yagel S, Adoni A. Early unwinding of torsion of an ovarian cyst as result of hyperstimulation syndrome. Fertil Steril: 1983; 40 3 393 394 (Pubitemid 13000582)
26. Gorkemli H, Camus M, Clasen K. Adnexal torsion after gonadotrophin ovulation induction for IVF or ICSI and its conservative treatment. Arch Gynecol Obstet: 2002; 267 1 4 6 (Pubitemid 36998763)
27. Roest J, Mous HV, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update: 1996; 2 4 345 353 (Pubitemid 26408114)
28. Schenker JG, Ezra Y. Complications of assisted reproductive techniques. Fertil Steril: 1994; 61 3 411 422 (Pubitemid 24083138)
29. Aragona C, Mohamed MA, Espinola MS., et al. Clinical complications after transvaginal oocyte retrieval in 7,098 IVF cycles. Fertil Steril: 2011; 95 1 293 294
30. Howe RS, Wheeler C, Mastroianni L Jr, Blasco L, Tureck R. Pelvic infection after transvaginal ultrasound-guided ovum retrieval. Fertil Steril: 1988; 49 4 726 728
31. Dicker D, Ashkenazi J, Feldberg D, Levy T, Dekel A, Ben-Rafael Z. Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer. Fertil Steril: 1993; 59 6 1313 1315 (Pubitemid 23163212)
32. Klemetti R, Sevn T, Gissler M, Hemminki E. Complications of IVF and ovulation induction. Hum Reprod: 2005; 20 12 3293 3300 (Pubitemid 41742503)
33. Rsquez F, Confino E. Can Doppler ultrasound-guided oocyte retrieval improve IVF safety? Reprod Biomed Online: 2010; 21 4 444 445
34. Sequeira PM. Anesthesia for in vitro fertilization. Int Anesthesiol Clin: 2003; 41 2 95 105 (Pubitemid 36459062)
35. The ESHRE Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod: 2000; 15 8 1856 1864
36. Grifo JA, Flisser E, Adler A., et al. Programmatic implementation of blastocyst transfer in a university-based in vitro fertilization clinic: maximizing pregnancy rates and minimizing triplet rates. Fertil Steril: 2007; 88 2 294 300 (Pubitemid 47212124)
37. Scotland GS, McLernon D, Kurinczuk JJ., et al. Minimising twins in in vitro fertilisation: a modelling study assessing the costs, consequences and cost-utility of elective single versus double embryo transfer over a 20-year time horizon. BJOG: 2011; 118 9 1073 1083
38. Wang YA, Kovacs G, Sullivan EA. Transfer of a selected single blastocyst optimizes the chance of a healthy term baby: a retrospective population based study in Australia 2004-2007. Hum Reprod: 2010; 25 8 1996 2005
39. Guerif F, Frapsauce C, Chavez C, Cadoret V, Royere D. Treating women under 36 years old without top-quality embryos on day 2: a prospective study comparing double embryo transfer with single blastocyst transfer. Hum Reprod: 2011; 26 4 775 781
40. Schoolcraft WB, Treff NR, Stevens JM, Ferry K, Katz-Jaffe M, Scott RT Jr. Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and single-nucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients. Fertil Steril: 2011; 96 3 638 640
41. Racowsky C, Ohno-Machado L, Kim J, Biggers JD. Is there an advantage in scoring early embryos on more than one day? Hum Reprod: 2009; 24 9 2104 2113
42. Chang HJ, Suh CS. Ectopic pregnancy after assisted reproductive technology: what are the risk factors? Curr Opin Obstet Gynecol: 2010; 22 3 202 207
43. Tal J, Haddad S, Gordon N, Timor-Tritsch I. Heterotopic pregnancy after ovulation induction and assisted reproductive technologies: a literature review from 1971 to 1993. Fertil Steril: 1996; 66 1 1 12 (Pubitemid 26190013)
44. Knutzen V, Stratton CJ, Sher G, McNamee PI, Huang TT, Soto-Albors C. Mock embryo transfer in early luteal phase, the cycle before in vitro fertilization and embryo transfer: a descriptive study. Fertil Steril: 1992; 57 1 156 162
45. Azem F, Yaron Y, Botchan A., et al. Ectopic pregnancy after in vitro fertilization-embryo transfer (IVF-ET): the possible role of the ET technique. J Assist Reprod Genet: 1993; 10 4 302 304
46. Pope CS, Cook EK, Arny M, Novak A, Grow DR. Influence of embryo transfer depth on in vitro fertilization and embryo transfer outcomes. Fertil Steril: 2004; 81 1 51 58 (Pubitemid 38058327)
47. Nazari A, Askari HA, Check JH, O'Shaughnessy A. Embryo transfer technique as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril: 1993; 60 5 919 921 (Pubitemid 23324785)
48. Flisser E, Grifo JA. Is what we clearly see really so obvious? Ultrasonography and transcervical embryo transfera review. Fertil Steril: 2007; 87 1 1 5 (Pubitemid 46013860)
49. Ali CR, Khashan AS, Horne G, Fitzgerald CT, Nardo LG. Implantation, clinical pregnancy and miscarriage rates after introduction of ultrasound-guided embryo transfer. Reprod Biomed Online: 2008; 17 1 88 93
50. Flisser E, Grifo JA, Krey LC, Noyes N. Transabdominal ultrasound-assisted embryo transfer and pregnancy outcome. Fertil Steril: 2006; 85 2 353 357 (Pubitemid 43170907)
51. Weinerman R, Mullin C. Use of ultrasound-guided embryo transfer reduces rates of extra-uterine pregnancies. Poster presented at: American Society for Reproductive Medicine Annual Meeting; October 19, 2011; Orlando, FL
52. Keegan DA, Morelli SS, Noyes N, Flisser ED, Berkeley AS, Grifo JA. Low ectopic pregnancy rates after in vitro fertilization: do practice habits matter? Fertil Steril: 2007; 88 3 734 736 (Pubitemid 47371234)
53. Milki AA, Jun SH. Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis. BMC Pregnancy Childbirth: 2003; 3 1 7 10
54. Rosman ER, Keegan DA, Krey L, Liu M, Licciardi F, Grifo JA. Ectopic pregnancy rates after in vitro fertilization: a look at the donor egg population. Fertil Steril: 2009; 92 5 1791 1793
55. Donadio NF, Donadio N, Martins PT, Cambiaghi Cde G. Heterotopic gestation: diagnostic possibility after in vitro fertilization. A case report [in Portuguese]. Rev Bras Ginecol Obstet: 2008; 30 9 466 469
56. Maruotti GM, Sarno L, Morlando M, Sirico A, Martinelli P, Russo T. Heterotopic pregnancy: it is really a rare event? The importance to exclude it not only after in vitro fertilization but also in case of spontaneous conception. Fertil Steril: 2010; 94 3 e49; author reply e50